[go: up one dir, main page]

SE9001906D0 - NEW APPLICATION FOR GLUCOSE - Google Patents

NEW APPLICATION FOR GLUCOSE

Info

Publication number
SE9001906D0
SE9001906D0 SE9001906A SE9001906A SE9001906D0 SE 9001906 D0 SE9001906 D0 SE 9001906D0 SE 9001906 A SE9001906 A SE 9001906A SE 9001906 A SE9001906 A SE 9001906A SE 9001906 D0 SE9001906 D0 SE 9001906D0
Authority
SE
Sweden
Prior art keywords
glucose
xylose
fructose
patient
infusion solution
Prior art date
Application number
SE9001906A
Other languages
Swedish (sv)
Other versions
SE502414C2 (en
SE9001906L (en
Inventor
O Ljungqvist
Original Assignee
Ljungqvist Olle Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ljungqvist Olle Medical Ab filed Critical Ljungqvist Olle Medical Ab
Priority to SE9001906A priority Critical patent/SE502414C2/en
Publication of SE9001906D0 publication Critical patent/SE9001906D0/en
Priority to PCT/SE1991/000376 priority patent/WO1991018610A1/en
Priority to AU79579/91A priority patent/AU7957991A/en
Publication of SE9001906L publication Critical patent/SE9001906L/en
Publication of SE502414C2 publication Critical patent/SE502414C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Glucose, fructose and/or xylose are suggested to be used for the preparation of an infusion solution intended for preoperative administration. An infusion solution is disclosed, which in addition to glucose, fructose and/or xylose and potassium chloride also contains glutamine and/or ornithine-alfa-ketoglutarate or the corresponding glutamine analogues which are transformed into glutamine in the body and possibly one or more hormones. Furthermore, a method is disclosed for suppressing the negative influence of an operation on patient carbohydrate metabolism after surgery and improving the defence capacity of the patient on bleeding in connection with or after the operation which method comprises preoperative intravenous administration to the patient of an infusion solution containing at least one carbohydrate selected from the group consisting of glucose, fructose and xylose.
SE9001906A 1990-05-28 1990-05-28 Use of glucose for preparation of solution for preoperative administration and infusion solution therefore SE502414C2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9001906A SE502414C2 (en) 1990-05-28 1990-05-28 Use of glucose for preparation of solution for preoperative administration and infusion solution therefore
PCT/SE1991/000376 WO1991018610A1 (en) 1990-05-28 1991-05-28 New use of glucose and a new solution of glucose
AU79579/91A AU7957991A (en) 1990-05-28 1991-05-28 New use of glucose and a new solution of glucose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001906A SE502414C2 (en) 1990-05-28 1990-05-28 Use of glucose for preparation of solution for preoperative administration and infusion solution therefore

Publications (3)

Publication Number Publication Date
SE9001906D0 true SE9001906D0 (en) 1990-05-28
SE9001906L SE9001906L (en) 1991-11-29
SE502414C2 SE502414C2 (en) 1995-10-16

Family

ID=20379607

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9001906A SE502414C2 (en) 1990-05-28 1990-05-28 Use of glucose for preparation of solution for preoperative administration and infusion solution therefore

Country Status (3)

Country Link
AU (1) AU7957991A (en)
SE (1) SE502414C2 (en)
WO (1) WO1991018610A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE469775B (en) * 1990-12-21 1993-09-13 Ljungqvist Olle Medical Ab Beverage for preoperative administration containing a carbohydrate mixture and use of saccharides to make the beverage
BR9506021A (en) 1994-07-01 1997-10-14 Baxter Int Peritoneal dialysis solution and process to correct metabolic acidosis
EP0875155A1 (en) * 1997-05-01 1998-11-04 N.V. Nutricia Peri-operative drink
US5968896A (en) * 1998-01-16 1999-10-19 Beth Israel Deaconess Medical Center Nutritional supplement for preoperative feeding
US6309673B1 (en) 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
WO2001035943A2 (en) * 1999-11-15 2001-05-25 Gangal Hanamaraddi T Dextrose and insulin fluid formulation for intravenous infusion
US7122210B2 (en) 2002-01-11 2006-10-17 Baxter International Inc. Bicarbonate-based solutions for dialysis therapies
US7445801B2 (en) 2002-06-07 2008-11-04 Baxter International Inc. Stable bicarbonate-based solution in a single container
EP1380290A1 (en) * 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-beta structure pathway and its therapeutic relevance
DE10257360A1 (en) * 2002-12-09 2004-07-08 Fresenius Kabi Deutschland Gmbh Gastrointestinally administrable formulation and its use
AU2004210266B2 (en) * 2003-02-06 2008-09-25 Otsuka Pharmaceutical Factory, Inc. Inhibitor for perioperative blood sugar elevation
US7935070B2 (en) 2005-01-28 2011-05-03 Fresenius Medical Care North America Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product
EP2033623A1 (en) * 2007-09-07 2009-03-11 Cutech S.R.L. Compositions comprising ornithine ketoglutarate (OKG)
FR2953719A1 (en) * 2009-12-10 2011-06-17 Luc Cynober NEW THERAPEUTIC APPLICATIONS OF A COMPLEX OF ALPHA-KETOGLUTARATE AND ORNITHINE
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser

Also Published As

Publication number Publication date
SE502414C2 (en) 1995-10-16
AU7957991A (en) 1991-12-31
WO1991018610A1 (en) 1991-12-12
SE9001906L (en) 1991-11-29

Similar Documents

Publication Publication Date Title
SE9001906L (en) NEW APPLICATION FOR GLUCOSE
CA2208047A1 (en) Increasing creatine and glycogen concentration in muscle
CO4700482A1 (en) FORMULATIONS OF A MONOMER INSULIN ANALOG
EA200000041A1 (en) METHOD OF TREATMENT OF DIABETES THIAZOLIDINDIONE AND METHORMIN
PE19496A1 (en) HUMAN INSULIN ANALOG FORMULATION
EP0137278A3 (en) Composition for transdermal drug application
EP0285776A3 (en) Surgical clip and apparatus for making the same
ATE239522T1 (en) INJECTION DEVICE
KR860006464A (en) 6-thioxanthine derivative
HU9301253D0 (en) Medical preparative applicable for treatment of enlarged time of coagulation
NO933000L (en) Use of C1 inactivator for the manufacture of a drug for the prophylaxis and treatment of certain diseases
CA2324522A1 (en) Hemofiltration device to independently control the concentration of at least two ionic substances in the patient's internal environment
KR840005342A (en) Intravenous fluid preparation
CA2113856A1 (en) Antidiabetic Agent
ATE325546T1 (en) USE OF A MODIFIED CARBOHYDRATE
KR920703112A (en) Pharmaceutical composition
KR940021067A (en) Energy supplemented sugar source and its use
KR880002527A (en) Eye composition for the treatment of neurodegeneration
EP1283044A3 (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
KR910002456A (en) Pharmaceutical composition for the treatment of diabetes
DE3586457D1 (en) SOLUBILIZATION PROCEDURE AT THE MOMENT OF THE USE OF AN ACTIVE LIPOPHILIC PRINCIPLE IN AQUEOUS SOLUTION FOR THE PURPOSE OF INTRAVENOUS ADMINISTRATION.
KR870010871A (en) Intraoperative Treatment of Basal Cell Carcinoma by Recombinant Human Alpha Interferon
JPS57128635A (en) Pharmaceutical preparation of gamma-globulin for venoclysis
DE3877363D1 (en) SYRINGE.
KR900017599A (en) Pharmaceutical composition for tumor treatment